Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from TATA Health International Holdings Ltd. ( (HK:1255) ) is now available.
TATA Health International Holdings Limited reported its annual financial results for the year ending December 31, 2024. The company experienced a significant decline in revenue from HK$207,542,000 in 2023 to HK$124,455,000 in 2024, alongside an increased loss before taxation, which rose from HK$35,420,000 to HK$68,031,000. The gross profit margin also decreased from 72.6% to 68.3%. These results indicate a challenging financial year for TATA Health, with increased losses impacting the company’s financial health and potentially affecting its market positioning.
More about TATA Health International Holdings Ltd.
Technical Sentiment Signal: Sell
Current Market Cap: HK$72.85M
Find detailed analytics on 1255 stock on TipRanks’ Stock Analysis page.